SystemOne Announces Winners of the Diagnostic-to-Treatment Grant

Mozambique and the Philippines National Tuberculosis Programs Win Grants to close the lab-clinic divide and confirm treatment for all positive TB cases

Springfield, MA, and Johannesburg, South Africa -- May 21, 2019 -- SystemOne is proud to announce the winners of its grant to help advance the fight against TB by connecting diagnostics to treatment. The competitive process attracted applications from across the globe. Instead of awarding a single grant, SystemOne has awarded two grants and will be working with National Tuberculosis Programs (NTP) in both the Philippines and Mozambique to connect new devices and help the fight against TB with diagnostic data.

“We were moved by the number and quality of the applications we received,” said Chris Macek, CEO, SystemOne. “The teams from both Mozambique and the Philippines provided impressive commitment to making diagnostic data flow and linking diagnosis to treatment, so we stretched ourselves to award two grants instead of one. SystemOne’s approach, which I call Diagnostic Accountability, focuses on ensuring that each positive diagnosis is linked to appropriate treatment.”

SystemOne’s in-kind services grants will ensure that data moves from several types of TB diagnostic devices to Aspect, the multi-disease, multi-device digital data platform. The data will then flow to the in-country TB case management system, which is different in each country. This connectivity with multiple instruments, and use of Aspect to link positive cases to treatment, is designed to dramatically reduce loss to follow-up, account for every positive diagnosis, and enable rapid electronic results reporting via SystemOne’s new Aspect Reporter app, or via email or SMS. The data must also integrate with current laboratory workflows to be most useful to the health system.

Also included in the grant is a data deep-dive to help local NTPs gain insight into how patients proceed through the diagnostic cascade and then onto treatment. The deep dive will analyze impact measurements on turnaround time, time to treatment initiation, and the gap between diagnosis and treatment -- as well as how the intervention helps to narrow that gap.

Go back